Equities
Health CarePharmaceuticals & Biotechnology
  • Price (USD)117.92
  • Today's Change1.67 / 1.44%
  • Shares traded3.43m
  • 1 Year change28.71%
  • Beta0.7952
Data delayed at least 15 minutes, as of Nov 15 2019 23:30 GMT.
More ▼

Key statistics

On Friday, Zoetis Inc (ZTS:NYQ) closed at 117.92, -9.43% below its 52-week high of 130.20, set on Oct 15, 2019.
52-week range
Today
78.90Dec 24 2018130.20Oct 15 2019
Markit short selling activity
Low
Med
High
Open116.72
High117.92
Low116.21
Bid--
Offer--
Previous close116.25
Average volume2.93m
Shares outstanding476.30m
Free float475.95m
P/E (TTM)38.62
Market cap56.17bn USD
EPS (TTM)3.05
USD
Annual div (ADY)0.656
USD
Annual div yield (ADY)0.56%
Div ex-dateOct 21 2019
Div pay-dateDec 02 2019
Data delayed at least 15 minutes, as of Nov 15 2019 23:30 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.